(Q44355814)

2 December 2017

title

Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss (English)

1 reference

2 December 2017

1 reference

Preston DM

1

1 reference

2 December 2017

Torréns JI

2

1 reference

2 December 2017

Harding P

3

1 reference

2 December 2017

Howard RS

4

1 reference

2 December 2017

Duncan WE

5

1 reference

2 December 2017

McLeod DG

6

1 reference

2 December 2017

publication date

1 January 2002

1 reference

Prostate Cancer and Prostatic Diseases

2 December 2017

published in

1 reference

2 December 2017

volume

5

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

304-310

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500599

2 December 2017

exact match

0 references

cites work

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Endocrine therapy of advanced carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Hormonal therapy in the management of prostate cancer: from Huggins to the present

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Evaluation and management of the man who has failed primary curative therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Bone fractures associated with luteinizing hormone-releasing hormone agonists used in the treatment of prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Severe osteoporosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Pathogenesis of vertebral crush fractures in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

1 reference

7 January 2021

Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

7 January 2021

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

7 January 2021

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

7 January 2021

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

7 January 2021

Determinants of the first decade of bone loss after menopause at spine, hip and radius

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500599

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500599

1 reference

2 December 2017

1 reference